Folic acid: friend or foe in cancer therapy

被引:5
|
作者
Thabet, Romany H. [1 ,2 ,5 ]
Alessa, Raneem Eid Mustafa [3 ]
Al-Smadi, Zahraa Khaldoon Khaleel [3 ]
Alshatnawi, Banah Saleh Gabr [3 ]
Amayreh, Batool Mahmoud Ibrahim [3 ]
Al-Dwaaghreh, Renad Bilal Ahmad [3 ]
Salah, Sereen Khalid Ahmad [4 ]
机构
[1] Assiut Univ, Fac Med, Dept Pharmacol, Assiut, Egypt
[2] Aqaba Med Sci Univ, Fac Med, Dept Basic Med Sci, Aqaba, Jordan
[3] Yarmouk Univ, Fac Med, Dept Basic Med Sci, Irbid, Jordan
[4] Princess Basma Hosp, Minist Hlth, Irbid, Jordan
[5] Aqaba Med Sci Univ, Fac Med, Dept Basic Med Sci, C12 Al Haddab,Parallel Rd,South Beach, Aqaba 77110, Jordan
关键词
Breast cancer; carcinogenic; colorectal cancer; folate; folic acid; lung cancer; prostate cancer; NEURAL-TUBE DEFECTS; DIETARY-FOLATE INTAKE; METHYLENETETRAHYDROFOLATE REDUCTASE C677T; ACUTE LYMPHOBLASTIC-LEUKEMIA; ONE-CARBON METABOLISM; PROSTATE-CANCER; FOOD FORTIFICATION; COLORECTAL-CANCER; PANCREATIC-CANCER; COLON-CANCER;
D O I
10.1177/03000605231223064
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Folic acid plays a crucial role in diverse biological processes, notably cell maturation and proliferation. Here, we performed a literature review using articles listed in electronic databases, such as PubMed, Scopus, MEDLINE, and Google Scholar. In this review article, we describe contradictory data regarding the role of folic acid in cancer development and progression. While some studies have confirmed its beneficial effects in diminishing the risk of various cancers, others have reported a potential carcinogenic effect. The current narrative review elucidates these conflicting data by highlighting the possible molecular mechanisms explaining each point of view. Further multicenter molecular and genetic studies, in addition to human randomized clinical trials, are necessary to provide a more comprehensive understanding of the relationship between folic acid and cancer.
引用
收藏
页数:19
相关论文
共 50 条
  • [31] HYDROCHLORIC-ACID - FRIEND OR FOE
    MORECOMBE, FA
    PHARMACOPEIAL FORUM, 1983, 9 (01): : 2655 - 2655
  • [32] Androgen deprivation therapy for prostate cancer: friend or foe to the cardiovascular system?
    Kaiping Zhang
    Li Zhang
    Zongyao Hao
    Chaozhao Liang
    World Journal of Urology, 2016, 34 : 879 - 881
  • [33] Androgen deprivation therapy for prostate cancer: friend or foe to the cardiovascular system?
    Zhang, Kaiping
    Zhang, Li
    Hao, Zongyao
    Liang, Chaozhao
    WORLD JOURNAL OF UROLOGY, 2016, 34 (06) : 879 - 881
  • [34] Pancreatic Cancer Stroma: Friend or Foe?
    Gore, Jesse
    Korc, Murray
    CANCER CELL, 2014, 25 (06) : 711 - 712
  • [35] MSC exosomes: a foe or friend of cancer?
    Lim, Sai Kiang
    CANCER SCIENCE, 2021, 112 : 986 - 986
  • [36] CANCER METABOLISM Tumour friend or foe
    Svensson, Robert U.
    Shaw, Reuben J.
    NATURE, 2012, 485 (7400) : 590 - 591
  • [37] Fibroblasts in cancer dormancy: foe or friend?
    Dai, Li
    Li, Mao
    Zhang, Wei-long
    Tang, Ya-Jie
    Tang, Ya-ling
    Liang, Xin-hua
    CANCER CELL INTERNATIONAL, 2021, 21 (01)
  • [38] Chemotherapy: Friend or foe to cancer vaccines?
    Emens, LA
    Machiels, JP
    Reilly, RT
    Jaffee, EM
    CURRENT OPINION IN MOLECULAR THERAPEUTICS, 2001, 3 (01) : 77 - 84
  • [39] Hydrogen sulfide in cancer: Friend or foe?
    Wu, Dongdong
    Si, Weirong
    Wang, Mingjie
    Lv, Shuangyu
    Ji, Ailing
    Li, Yanzhang
    NITRIC OXIDE-BIOLOGY AND CHEMISTRY, 2015, 50 : 38 - 45
  • [40] Editorial: Anesthesia and cancer: Friend or foe?
    Bezu, Lucillia
    Diaz-Cambronero, Oscar
    Kepp, Oliver
    FRONTIERS IN ONCOLOGY, 2022, 12